908 Devices Inc(MASS)
USD --+0.00%
Reward55Moderate
Risk39Moderate
📊75%Data
Thin -6% profit margin
MASS
+0.0 · +0.00%
USD · NASDAQ
908 Devices Inc | Healthcare
Profitless Growth
Market Cap:246.84M
ℹ️
Reward Rating
55
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
39
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MASS to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $10.00.

What is 908 Devices Inc?

, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets.

MASS · Verdict

Solid reward · moderate risk

MASS stands out on balance sheet and volatility, but watch the profitability signal.

Based on 88% data coverage

MASS · Verdict

What’s working & what to watch

Strengths 4

  • Balance sheet86/100

    Current ratio 4.10

  • Volatility80/100

    Top decile vs peers

  • Growth70/100

    Rev +12.2% CAGR · earnings +48.2%

  • Valuation65/100

    Above average

Watchouts 2

  • Profitability24/100

    -121% net margin · -54% ROE

  • Cash flow25/100

    -52% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is 908 Devices Inc?

, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as process fingerprint data to support large-scale efforts in predictive bioprocess modeling. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 246.84M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (55)

The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap246.84M
P/E RatioN/A
Dividend YieldN/A
52 Week High9.34
52 Week Low1.92
Last AnnualDecember
IPO Date12/18/2020
IncorporatedUSA
Shares Outstanding36M
No. of Employees246
IndustryMedical Devices
ExchangeNASDAQ
Beta0.487
CurrencyUSD